Overview

  • Product nameAnti-FRA1 antibody
    See all FRA1 primary antibodies
  • Description
    Rabbit polyclonal to FRA1
  • Tested applicationsSuitable for: ELISA, WBmore details
  • Species reactivity
    Reacts with: Mouse, Human
    Predicted to work with: Rat
  • Immunogen

    Synthetic peptide derived from an internal sequence of human FRA1

  • Positive control
    • HT-29 cell extracts.

Properties

Applications

Our Abpromise guarantee covers the use of ab65051 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ELISA 1/20000.
WB 1/500 - 1/1000. Detects a band of approximately 40 kDa (predicted molecular weight: 29 kDa).

Target

Anti-FRA1 antibody images

  • All lanes : Anti-FRA1 antibody (ab65051) at 1/500 dilution

    Lane 1 : HT-29 cell extract
    Lane 2 : HT-29 cell extract with immunising peptide at 5 µg

    Lysates/proteins at 5 µg per lane.


    Predicted band size : 29 kDa
    Observed band size : 40 kDa (why is the actual band size different from the predicted?)

References for Anti-FRA1 antibody (ab65051)

This product has been referenced in:
  • Baker EK  et al. BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells. Sci Rep 5:10120 (2015). WB ; Human . Read more (PubMed: 25944566) »
  • Mitchell J  et al. ß2-adrenergic receptors inhibit the expression of collagen type II in growth plate chondrocytes by stimulating the AP-1 factor Jun-B. Am J Physiol Endocrinol Metab 300:E633-9 (2011). WB ; Mouse . Read more (PubMed: 21177286) »

See all 2 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab65051.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"